192 related articles for article (PubMed ID: 26578081)
1. Anxiolytic-Like Effects of Increased Ghrelin Receptor Signaling in the Amygdala.
Jensen M; Ratner C; Rudenko O; Christiansen SH; Skov LJ; Hundahl C; Woldbye DP; Holst B
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26578081
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic effects of 5-HT₁A receptors and anxiogenic effects of 5-HT₂C receptors in the amygdala of mice.
Li Q; Luo T; Jiang X; Wang J
Neuropharmacology; 2012 Jan; 62(1):474-84. PubMed ID: 21925519
[TBL] [Abstract][Full Text] [Related]
3. Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
Strauss CV; Vicente MA; Zangrossi H
Behav Brain Res; 2013 Jun; 246():103-10. PubMed ID: 23499701
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice.
Christiansen SH; Olesen MV; Gøtzsche CR; Woldbye DP
Neuropeptides; 2014 Dec; 48(6):335-44. PubMed ID: 25267070
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin alleviates anxiety- and depression-like behaviors induced by chronic unpredictable mild stress in rodents.
Huang HJ; Zhu XC; Han QQ; Wang YL; Yue N; Wang J; Yu R; Li B; Wu GC; Liu Q; Yu J
Behav Brain Res; 2017 May; 326():33-43. PubMed ID: 28245976
[TBL] [Abstract][Full Text] [Related]
6. Activation of urocortin 1 and ghrelin signaling in the basolateral amygdala induces anxiogenesis.
Currie PJ; Schuette LM; Wauson SE; Voss WN; Angeles MJ
Neuroreport; 2014 Jan; 25(1):60-4. PubMed ID: 24113112
[TBL] [Abstract][Full Text] [Related]
7. Midbrain raphe 5-HT1A receptor activation alters the effects of ghrelin on appetite and performance in the elevated plus maze.
Wauson SE; Sarkodie K; Schuette LM; Currie PJ
J Psychopharmacol; 2015 Jul; 29(7):836-44. PubMed ID: 25922422
[TBL] [Abstract][Full Text] [Related]
8. Schisandrin B alleviates acute oxidative stress via modulation of the Nrf2/Keap1-mediated antioxidant pathway.
Wu Y; Li ZC; Yao LQ; Li M; Tang M
Appl Physiol Nutr Metab; 2019 Jan; 44(1):1-6. PubMed ID: 29742356
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.
Nakamura K; Kurasawa M
Eur J Pharmacol; 2001 May; 420(1):33-43. PubMed ID: 11412837
[TBL] [Abstract][Full Text] [Related]
10. Desacyl Ghrelin Decreases Anxiety-like Behavior in Male Mice.
Mahbod P; Smith EP; Fitzgerald ME; Morano RL; Packard BA; Ghosal S; Scheimann JR; Perez-Tilve D; Herman JP; Tong J
Endocrinology; 2018 Jan; 159(1):388-399. PubMed ID: 29155981
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
Vicente MA; Zangrossi H
Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
[TBL] [Abstract][Full Text] [Related]
12. Acute But Not Chronic Calorie Restriction Defends against Stress-Related Anxiety and Despair in a GHS-R1a-Dependent Manner.
Lu Y; Niu M; Qiu X; Cao H; Xing B; Sun Y; Zhou Z; Zhou Y
Neuroscience; 2019 Aug; 412():94-104. PubMed ID: 31185255
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models.
Scheich B; Gaszner B; Kormos V; László K; Ádori C; Borbély É; Hajna Z; Tékus V; Bölcskei K; Ábrahám I; Pintér E; Szolcsányi J; Helyes Z
Neuropharmacology; 2016 Feb; 101():204-15. PubMed ID: 26387439
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system.
Zarrindast MR; Sroushi A; Bananej M; Vousooghi N; Hamidkhaniha S
Eur J Pharmacol; 2011 Dec; 672(1-3):106-12. PubMed ID: 21968140
[TBL] [Abstract][Full Text] [Related]
15. Acid sensing ion channel (ASIC) inhibitors exhibit anxiolytic-like activity in preclinical pharmacological models.
Dwyer JM; Rizzo SJ; Neal SJ; Lin Q; Jow F; Arias RL; Rosenzweig-Lipson S; Dunlop J; Beyer CE
Psychopharmacology (Berl); 2009 Mar; 203(1):41-52. PubMed ID: 18949460
[TBL] [Abstract][Full Text] [Related]
16. Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice.
Tasan RO; Lin S; Hetzenauer A; Singewald N; Herzog H; Sperk G
Neuroscience; 2009 Feb; 158(4):1717-30. PubMed ID: 19121371
[TBL] [Abstract][Full Text] [Related]
17. Effects of a hydroethanolic extract of Boophone disticha bulb on anxiety-related behaviour in naive BALB/c mice.
Pote W; Musarira S; Chuma D; Gadaga LL; Mwandiringana E; Tagwireyi D
J Ethnopharmacol; 2018 Mar; 214():218-224. PubMed ID: 29223391
[TBL] [Abstract][Full Text] [Related]
18. Characterization of 6-methoxyflavanone as a novel anxiolytic agent: A behavioral and pharmacokinetic approach.
Akbar S; Subhan F; Karim N; Aman U; Ullah S; Shahid M; Ahmad N; Fawad K; Sewell RD
Eur J Pharmacol; 2017 Apr; 801():19-27. PubMed ID: 28257822
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze.
Gonzalez LE; Andrews N; File SE
Brain Res; 1996 Sep; 732(1-2):145-53. PubMed ID: 8891278
[TBL] [Abstract][Full Text] [Related]
20. Hemokinin-1 mediates anxiolytic and anti-depressant-like actions in mice.
Borbély É; Hajna Z; Nabi L; Scheich B; Tékus V; László K; Ollmann T; Kormos V; Gaszner B; Karádi Z; Lénárd L; Paige CJ; Quinn JP; Szolcsányi J; Pintér E; Keeble J; Berger A; Helyes Z
Brain Behav Immun; 2017 Jan; 59():219-232. PubMed ID: 27621226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
